- French biotech Nanobiotix ( NASDAQ: NBTX ) on Tuesday said it had reached a final agreement with the European Investment Bank (EIB) to re-align about €30.7M in outstanding debt obligations with its expected development and commercialization timelines.
- The company had previously announced the agreement-in-principle with the EIB in mid-Sept.
- As per the newly executed final agreement, NBTX can now defer repayment of the remaining €25.3M of the loan set to be paid in two tranches up to June 2029.
- The restructuring agreement also includes a new milestone payment of €20M due in June 2029.
- U.S.-listed shares of NBTX -2.4% to $4 after hours.
For further details see:
Nanobiotix enters final agreement to restructure existing loan with EU's investment bank